Sonnet BioTherapeutics shares are trading lower after the company announced the exercise of warrants for gross proceeds of $3.4 million.
Portfolio Pulse from Benzinga Newsdesk
Sonnet BioTherapeutics shares are trading lower after the company announced the exercise of warrants for gross proceeds of $3.4 million.
June 20, 2024 | 3:48 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Sonnet BioTherapeutics shares are trading lower after the company announced the exercise of warrants for gross proceeds of $3.4 million.
The exercise of warrants typically leads to an increase in the number of shares outstanding, which can dilute the value of existing shares. This is likely why Sonnet BioTherapeutics shares are trading lower.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100